{"nct_id":"NCT00708162","title":"Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir","status":"COMPLETED","status_verified_date":"2016-04","start_date":"2008-07","start_date_type":null,"primary_completion_date":"2010-12","primary_completion_date_type":"ACTUAL","completion_date":"2015-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}